Update on HER2-Targeted Therapy in Early Breast Cancer

home / investigator-perspectives / update-on-her2-targeted-therapy-in-early-breast-cancer

Sara M. Tolaney, MD, MPH, discusses newer approaches to managing early stages of HER2+ breast cancer in both the neoadjuvant and adjuvant spaces.

HER2 Assessment in Breast Cancer

EP. 1: HER2 Assessment in Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

Neoadjuvant Approaches for Early-Stage HER2+ Breast Cancers

EP. 2: Neoadjuvant Approaches for Early-Stage HER2+ Breast Cancers

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

HER2 Heterogeneity and Neoadjuvant Therapy in Breast Cancer

EP. 3: HER2 Heterogeneity and Neoadjuvant Therapy in Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

Neoadjuvant T-DM1 in Early-Stage HER2+ Breast Cancer

EP. 4: Neoadjuvant T-DM1 in Early-Stage HER2+ Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

The APHINITY Trial in Early-Stage HER2+ Breast Cancer

EP. 5: The APHINITY Trial in Early-Stage HER2+ Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

Adjuvant T-DM1 Therapy for Early-Stage HER2+ Breast Cancer

EP. 6: Adjuvant T-DM1 Therapy for Early-Stage HER2+ Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

The ExteNET Study & Management of HER2+ Breast Cancer

EP. 7: The ExteNET Study & Management of HER2+ Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch

Novel Approaches for Stage I HER2+ Breast Cancer

EP. 8: Novel Approaches for Stage I HER2+ Breast Cancer

Sara M. Tolaney, MD, MPH
May 11th 2020

Watch